Xenetic Biosciences Stock Analysis

Xenetic Stock Analysis Notes

About 19.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 1.1. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Xenetic Biosciences recorded a loss per share of 2.33. The entity last dividend was issued on the 25th of June 2019. The firm had 1:10 split on the 15th of May 2023. Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell platform technology engineered to target patient-specific tumor neoantigens. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts. Xenetic Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people. For more information please call the company at 781 778 7720 or visit https://www.xeneticbio.com.

Xenetic Biosciences Investment Alerts

Xenetic Biosciences Upcoming and Recent Events

Xenetic Largest EPS Surprises

View All Earnings Estimates

Xenetic Biosciences Environmental, Social, and Governance (ESG) Scores

Xenetic Stock Institutional Investors

Note, although Xenetic Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Xenetic Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.62 M.

Xenetic Profitablity

The company has Profit Margin (PM) of (1.42) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.59) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.59.

Management Efficiency

Xenetic Biosciences has return on total asset (ROA) of (0.3193) % which means that it has lost $0.3193 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5316) %, meaning that it created substantial loss on money invested by shareholders. Xenetic Biosciences' management efficiency ratios could be used to measure how well Xenetic Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of July 2025, Return On Tangible Assets is likely to drop to -0.6. In addition to that, Return On Capital Employed is likely to drop to -0.73. At this time, Xenetic Biosciences' Asset Turnover is very stable compared to the past year.

Technical Drivers

As of the 23rd of July, Xenetic Biosciences maintains the Downside Deviation of 4.61, mean deviation of 3.78, and Market Risk Adjusted Performance of (1.71). Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Xenetic Biosciences, as well as the relationship between them.

Xenetic Biosciences Price Movement Analysis

Xenetic Biosciences Insider Trading Activities

Xenetic Biosciences Outstanding Bonds

Xenetic Biosciences Predictive Daily Indicators

Xenetic Biosciences Forecast Models

Xenetic Biosciences' time-series forecasting models are one of many Xenetic Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Xenetic Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Xenetic Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Xenetic shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Xenetic Biosciences. By using and applying Xenetic Stock analysis, traders can create a robust methodology for identifying Xenetic entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Xenetic analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Xenetic analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Xenetic Biosciences stock analysis indicators help investors evaluate how Xenetic Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Xenetic Biosciences shares will generate the highest return on investment. By understating and applying Xenetic Biosciences stock analysis, traders can identify Xenetic Biosciences position entry and exit signals to maximize returns.

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xenetic Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Xenetic Stock, please use our How to Invest in Xenetic Biosciences guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xenetic Biosciences. If investors know Xenetic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xenetic Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Xenetic Biosciences is measured differently than its book value, which is the value of Xenetic that is recorded on the company's balance sheet. Investors also form their own opinion of Xenetic Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Xenetic Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xenetic Biosciences' market value can be influenced by many factors that don't directly affect Xenetic Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Xenetic Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Xenetic Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xenetic Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.